Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
allogeneic adipose-derived adult mesenchymal stem cells
- Development stage
- Unknown
- Lead developer
- Fundación de Investigación Biomédica de Salamanca
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Ophthalmic, Intravenous
01
Overview
Allogeneic adipose-derived adult mesenchymal stem cells (Ad-MSCs) are an investigational cell therapy developed by the Fundacion De Investigacion Biomedica De Salamanca for the treatment of inflammatory conditions, specifically severe dry eye disease associated with chronic graft-versus-host disease (cGvHD). These cells are isolated from the adipose tissue of healthy donors and expanded in vitro. They possess potent immunomodulatory properties, acting through the secretion of paracrine factors such as interleukin-10 (IL-10) and transforming growth factor-beta (TGF-β), as well as through direct cell-to-cell contact with immune cells like T-lymphocytes. In the context of dry eye, they are typically administered as an ophthalmic solution to reduce ocular surface inflammation and promote the repair of the lacrimal apparatus.
- Other names
- allogeneic adipose-derived mesenchymal stem cellsallogeneic adipose-derived adult mesenchymal stem cells
Beyond the preview
Go deeper on allogeneic adipose-derived adult mesenchymal stem cells.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on allogeneic adipose-derived adult mesenchymal stem cells.